According to recent reports participants are now being enrolled by Columbia University in a Phase II clinical trial into a treatment program that could help to treat people that have pleural, peritoneal, or pericardial mesothelioma, which are types of cancer that are caused by exposure to asbestos.

There is currently no cure for this type of cancer, which can take decades to develop from the time of exposure. The University is aiming to test the effectiveness of a chemotherapy drug treatment program during the Phase II trial. The trial was test the effectiveness of a combination of the drugs oxaliplatin and gemcitabine in treatming mesothelioma patients.

The report claimed that previous studies had shown that a combination of these two drugs had some level of effect on certain mesothelioma sufferers, and last year researchers from the Respiratory Disease Clinic Heckeshorn said that when administered to patients every twenty one days the treatment was able to control progression of the cancer.

As part of this Phase II trail twenty nine patients in total will be enrolled, and the trial is set to last for a period of around six months. Participants will have to fit thje criteria, and must be aged eighteen or over. They must also have been diagnosed with mesothelioma, which cannot be treated with surgery.

Be Sociable, Share!